biotech | EvoNexus

Nanomedical Diagnostics Announces Peer-Reviewed Publication Demonstrating High Sensitivity and Selectivity With the AGILE R100 Label-Free Electronic Assay

Posted on October 11, 2016 by Danielle Toledo — No Comments ↓

Co-authored by scientists from UCSD and UCI, the publication highlights enzyme, antibody, and insulin experiments that showcase AGILE R100’s ability to exceed current protein characterization methods. SAN DIEGO, CA (PRWEB) OCTOBER 11, 2016 Nanomedical Diagnostics, a biotech company driving the…

Tagged with: biotech, Nanoscience, San Diego biotech, san diego graphene, UCSD
Posted in News

StemoniX Raises $2.5 million

Posted on October 10, 2016 by Danielle Toledo — No Comments ↓

EvoNexus company, StemoniX raised $2.5 million seed round. The new funds came from SEED San Diego, Gopher Angels, and Oklahoma Angels. StemoniX graduated from the EvoNexus incubator in May 2016 after one year in the EvoNexus La Jolla office. During their…

Tagged with: biotech, San Diego, socaltech, Stemonix, tech
Posted in Blog

Blog Archives

Nanomedical Diagnostics Announces Peer-Reviewed Publication Demonstrating High Sensitivity and Selectivity With the AGILE R100 Label-Free Electronic Assay

StemoniX Raises $2.5 million